Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Vopr Virusol ; 65(1): 21-26, 2020.
Artigo em Russo | MEDLINE | ID: mdl-32496717

RESUMO

INTRODUCTION: The well-known advantages of class Y antibodies (IgY) from egg yolks of immunized hens in comparison with class G antibodies (IgG) of laboratory animals traditionally used in laboratory diagnosis of infectious diseases determine the stable interest of researchers in using IgY for these purposes (IgY technology). Over the past 20 years, the obvious benefits of IgY technology have been demonstrated for a number of viral and bacterial infections. Goals and objectives. Construction of ELISA systems based on specific IgY for laboratory diagnosis of infections caused by tick-borne encephalitis virus, yellow fever virus, poliovirus. MATERIAL AND METHODS: Obtaining yolk preparations of immunized chickens, obtaining highly purified IgY preparations (salting out, affinity chromatography), constructing ELISA systems for determining virus-specific antigens, testing the parameters of ELISA systems. RESULTS AND DISCUSSION: For the first time in laboratory practice, ELISA systems based on the use of specific polyclonal IgY were designed for laboratory diagnosis of topical human viral infections caused by flaviviruses and enteroviruses: determination of antigens of tick-borne encephalitis virus, yellow fever virus, 3 types of poliovirus. It was experimentally shown that these ELISA systems have high sensitivity and specificity, which allows them to be used for the semiquantitative and quantitative determination of antigens of these viruses in various materials (infected cell cultures, vaccines, etc.). CONCLUSION: The ELISA systems developed on the basis of specific IgY for determination of viral antigens can be effectively used for laboratory diagnosis of a number of viral infections, for the validation and control of vaccine preparations.


Assuntos
Técnicas de Laboratório Clínico , Gema de Ovo/imunologia , Imunoglobulinas/isolamento & purificação , Viroses/diagnóstico , Animais , Galinhas/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunização , Poliovirus/imunologia , Poliovirus/isolamento & purificação , Viroses/imunologia
2.
Vopr Virusol ; 65(4): 212-217, 2020 Sep 17.
Artigo em Russo | MEDLINE | ID: mdl-33533224

RESUMO

INTRODUCTION: The only currently available live vaccine against yellow fever (YF) based on chicken embryos infected with an attenuated 17D strain of the YF virus is one of the most effective vaccine preparations. However, the live vaccine is associated with "viscerotropic syndrome" (approximately 0.4 cases per 100 000 vaccinated). Therefore, the development and introduction of highly purified inactivated vaccine against YF is intended to ensure the maximum safety of vaccination against one of the most common human viral diseases.Goals and objectives. Development and evaluation of immunogenicity of the cultural inactivated vaccine against YF at the laboratory model level. MATERIAL AND METHODS: Adaptation of 17D strain of YF virus to Vero cell culture, cultivation, removal of cellular DNA, inactivation with ß-propiolactone, concentration, chromatographic purification, determination of protein and antigen of YF virus, assessment of immunogenicity in mice in parallel with commercial live vaccine. RESULTS AND DISCUSSION: Immunogenicity: the determination of specific antibodies of class G (IgG) and virus neutralizing antibodies in the sera of immunized mice showed high level of antibodies exceeding that of immunized with commercial live vaccine. The optimal dose of antigen in the vaccine (total protein) was 50 µg/ml (5 µg/0.1 ml -dose and volume per 1 vaccination of mice). Thus, the laboratory version of cultural inactivated vaccine against YF is as effective (and even superior) as the commercial live vaccine. CONCLUSION: Laboratory version of cultural inactivated vaccine against YF, which is not inferior in immunogenicity (in animal model) to commercial live vaccine, has been developed.


Assuntos
Vacinas Atenuadas/farmacologia , Vacina contra Febre Amarela/farmacologia , Febre Amarela/tratamento farmacológico , Vírus da Febre Amarela/efeitos dos fármacos , Animais , Anticorpos Neutralizantes/isolamento & purificação , Anticorpos Antivirais/isolamento & purificação , Antígenos Virais/isolamento & purificação , Chlorocebus aethiops , Feminino , Humanos , Camundongos , Vacinas Atenuadas/imunologia , Células Vero , Febre Amarela/genética , Febre Amarela/virologia , Vírus da Febre Amarela/genética , Vírus da Febre Amarela/patogenicidade
3.
Vopr Virusol ; 59(6): 39-42, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25929036

RESUMO

The results of the construction of the first Russian ELISA system for the quantitative determination of D-antigen of 1-3 poliovirus types in the preparations of inactivated poliovirus vaccines are presented. For the first time, this kind of system is based on the use of specific antibodies of class Y (IgY) from egg yolks of immunized hens. It was shown that this ELISA system is specific, sufficiently sensitive, and can be used for quantitative determination of D-antigen of 1-3 poliovirus types in inactivated poliovirus vaccines.


Assuntos
Anticorpos Antivirais/análise , Antígenos Virais/imunologia , Ensaio de Imunoadsorção Enzimática/métodos , Imunoglobulinas/análise , Poliomielite/diagnóstico , Poliomielite/prevenção & controle , Animais , Anticorpos Antivirais/biossíntese , Anticorpos Antivirais/isolamento & purificação , Galinhas/imunologia , Gema de Ovo/química , Gema de Ovo/imunologia , Ensaio de Imunoadsorção Enzimática/normas , Feminino , Humanos , Imunização , Imunoglobulinas/biossíntese , Imunoglobulinas/isolamento & purificação , Poliomielite/imunologia , Poliomielite/virologia , Poliovirus/imunologia , Vacina Antipólio de Vírus Inativado/administração & dosagem , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA